Certified by Founder Lodge
Qlaris Bio, Inc.
United States - Wellesley, Massachusetts
START UP
1 Disclosed Funding Rounds $24,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Qlaris, our lead program is QLS-111, a novel topical ocular therapy that lowers intraocular pressure with a unique mechanism of action. QLS-111 is distinct from currently available therapi
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 30 ,2024 | Series B | $24,000,000 |
Correlation Ventures
Mayo Clinic
Canaan
New Leaf Venture Partners
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
